alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7953 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7953

To amend title 10, United States Code, to allow members of the Selected 
   Reserve and National Guard holding employment within the Federal 
 Government the choice between military and civilian healthcare plans, 
                        and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 11, 2024

   Mrs. Kiggans of Virginia (for herself, Mr. Kim of New Jersey, Mr. 
    Wittman, Mr. Turner, Mr. Gimenez, and Mr. Kelly of Mississippi) 
 introduced the following bill; which was referred to the Committee on 
                             Armed Services

_______________________________________________________________________

                                 A BILL

 
To amend title 10, United States Code, to allow members of the Selected 
   Reserve and National Guard holding employment within the Federal 
 Government the choice between military and civilian healthcare plans, 
                        and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Servicemember Healthcare Freedom Act 
of 2024''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) Thousands of members of reserve components and the 
        National Guard, in addition to their military service, work for 
        the United States Government in a civilian capacity.
            (2) Nearly all members of the Selected Reserve and the 
        National Guard, and their families, are entitled to purchase a 
        TRICARE Reserve Select (TRS) healthcare plan as a service-
        related benefit.
            (3) As of the day before the date of the enactment of this 
        Act, eligibility for Federal Employee Health Benefits (FEHB) 
        prohibits members of the Selected Reserve and National Guard 
        from enrolling in Tricare Reserve Select plans.
            (4) Removal of such prohibition for members of the Selected 
        Reserve and the National Guard will provide continuity of care 
        throughout mobilization cycles.
            (5) Providing members of the Armed Forces with the ability 
        to purchase comprehensive, low-cost health insurance increases 
        the readiness and lethality of the Armed Forces as a whole.

SEC. 3. MODIFICATION OF EXPIRATION DATE TO ALLOW MEMBERS OF THE 
              SELECTED RESERVE AND NATIONAL GUARD, ELIGIBLE FOR FEDERAL 
              EMPLOYEE HEALTH BENEFITS, TO ENROLL INTO TRICARE RESERVE 
              SELECT AS OF JANUARY 1, 2025.

    Section 1076d(a)(2) of title 10, United States Code, is amended by 
striking ``January 1, 2030'' and inserting ``January 1, 2025''.
                                 <all>
```
EXHIBIT 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       ARMANINO FOODS OF DISTINCTION, INC.
                       PURSUANT TO 18 U.S.C. SECTION 1350


     I hereby certify that, to the best of my knowledge, the Quarterly Report
on Form 10-QSB of Armanino Foods of Distinction, Inc. for the period ending
March 31, 2004:

     (1) complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

     (2) the information contained in the Report fairly presents, in all
material aspects, the financial condition and results of operations of
Armanino Foods of Distinction, Inc.





/s/ William J. Armanino
William J. Armanino
Chief Executive Officer
April 27, 2004


A signed original of this written statement required by Section 906 of the
Sarbanes-Oxley Act of 2002 has been provided to Armanino Foods of Distinction,
Inc. and will be retained by Armanino Foods of Distinction, Inc. and furnished
to the Securities and Exchange Commission upon request.
**Exhibit31.1**

**CERTIFICATION**

I, Robin Raina, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Ebix, Inc.;

2. Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material fact necessary to makethe statements made, in light of the circumstances under which such statementswere made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all material respectsthe financial condition, results of operations and cash flows of the registrantas of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, toensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the registrant’s disclosure controlsand procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of theperiod covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during the registrant’s mostrecent fiscal quarter (the registrant’s fourth fiscal quarter in the case of anannual report) that has materially affected, or is reasonably likely tomaterially affect, the registrant’s internal control over financial reporting;and

5. The registrant’s other certifying officer and I have disclosed,based on our most recent evaluation of internal control over financialreporting, to the registrant’s auditors and the audit committee of theregistrant’s board of directors (or persons performing the equivalentfunctions):

(a) All significant deficiencies and material weaknesses in the designor operation of internal control over financial reporting which are reasonablylikely to adversely affect the registrant’s ability to record, process,summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’s internalcontrol over financial reporting.

 
| Date:  August 14, 2006 | /s/ Robin Raina          |   |
|----------------------------------|--------------------------|--------|
|                             | Robin Raina              |   |
|                             | Chief Executive  Officer |

 

----
Certificate of Trust of BAC Capitla Trust V


EXHIBIT 4.2 
 
CERTIFICATE OF TRUST 
 
The undersigned, the trustees of BAC Capital Trust V, desiring to form a statutory trust pursuant to Delaware Statutory Trust Act, 12
Del. C. § 3810, hereby certify as follows: 
 

	 	(a)	 	The name of the statutory trust being formed hereby (the “Trust”) is “BAC Capital Trust V.” 

 

	 	(b)	 	The name and business address of the trustee of the Trust which has its principal place of business in the State of Delaware is as follows:


 
The Bank of New
York (Delaware) 
502 White Clay Center, Route 273 
Newark, Delaware 19711 
 

	 	(c)	 	This Certificate of Trust shall be effective as of the date of filing. 

 
Dated:  March 14, 2003 
 

	
	 	 	 /s/    JAMES T.
HOUGHTON        


	 Name:
	 	 James T. Houghton

	 Title:
	 	 Regular Trustee

	
	 	 	 /s/    KAREN A.
GOSNELL        


	 Name:
	 	 Karen A. Gosnell

	 Title:
	 	 Regular Trustee

	
	 THE BANK OF NEW
YORK

	 (Delaware), as Delaware Trustee

	
	 By:
	 	 /s/    PATRICK
BURNS        


	 Name:
	 	 Patrick Burns

	 Title:
	 	 Senior Vice President
#### § 207.5 What is the purpose of this part?

Establishment registration information helps FDA identify who is manufacturing, repacking, relabeling, and salvaging drugs and where those operations are performed. Drug listing information gives FDA a current inventory of drugs manufactured, repacked, relabeled, or salvaged for commercial distribution. Both types of information facilitate implementation and enforcement of the Federal Food, Drug, and Cosmetic Act and are used for many important public health purposes.
#### Edwards *et al. v.*The State.

Atkinson, J.

The motion for a new trial was based on the general grounds, and one special ground alleging discovery, after verdict, of evidence, showing disqualification of one of the jurors on account of his relation to the deceased within the degree prohibited by law. At the hearing the defendants introduced evidence to support that ground, and the State did not make any counter-showing. After argument the judge overruled the motion for a new trial, “because the court has already granted one new trial in said case, and the jury has again convicted the defendants; and the court is doubtful as to whether . . the evidence . . is sufficient to sustain the conviction . . and desires the Supreme Court to pass on the sufficiency of the evidence.” *Held:*

*633No. 8859.

March 16, 1932.

*E. K. Overstreet Jr., Hugh B. Tarver Jr.,*and *J. W. Usher,*for plaintiffs in error.

*George M. Napier, attorney-general, W. G. Neville, solicitor-general,*and *T. B. Gress, assistant attorney-general,*contra.

1. The refusal to grant a new trial on the special ground relating to disqualification of the juror was reversible error.

2. As the ease will go back for another trial, where the evidence may not be the same, this court, following the usual practice, will not rule upon the sufficiency of the evidence to support the verdict.

*Judgment reversed.*

*All the Justices eoneur.*
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### International Trade Administration

# AGENCY:

International Trade Administration, U.S. Department of Commerce.

# ACTION:

Notice of an open meeting.

# SUMMARY:

The Manufacturing Council will hold a meeting to discuss a variety of issues affecting the U.S. manufacturing industry. The Council was re-chartered on April 10, 2008, to advise the Secretary of Commerce on matters relating to the U.S. manufacturing industry.

# DATES:

March 22, 2010.

*Time:*                         1:30-3 p.m. (ET).                    

# ADDRESSES:

                        Department of Commerce, 1401 Constitution Avenue, NW., Room 4830, Washington, DC, 20230. Because of building security, all non-government attendees must pre-register. This program will be physically accessible to people with disabilities. Seating is limited and will be on a first come, first served basis. Requests for sign language interpretation, other auxiliary aids, or pre-registration, should be submitted no later than March 15, 2010, to J. Marc Chittum, the Manufacturing Council, Room 4043, 1401 Constitution Avenue, NW., Washington, DC, 20230, telephone 202-482-4501,                         *Marc.Chittum@trade.gov.*

# FOR FURTHER INFORMATION CONTACT:

                        J. Marc Chittum, the Manufacturing Council, Room 4043, 1401 Constitution Avenue, NW., Washington, DC, 20230, telephone: 202-482-4501, e-mail:                         *Marc.Chittum@trade.gov*.                    

Dated: March 1, 2010.

J. Marc Chittum

Executive Secretary, the Manufacturing Council.

[FR Doc. 2010-4797 Filed 3-4-10; 8:45 am]

BILLING CODE 3510-DR-P
# C_2014329EN.01001402.xml

| 22.9.2014 | EN | Official Journal of the European Union | C 329/14 |
| --- | --- | --- | --- |

22.9.2014

EN

Official Journal of the European Union

C 329/14

---

Order of the President of the General Court of 10 June 2014 — WeserWind v Commission

(Case T-173/14 R)

((Interim measures - State aid - National promotion of electricity production from a renewable source - Commission decision to open formal investigation procedure in respect of State aid - Application for suspension of operation of a measure - Urgency - Fumus boni juris))

2014/C 329/18

Language of the case: German

Parties

Parties

Applicant: WeserWind GmbH Offshore Construction Georgsmarienhütte (Bremerhaven, Germany) (represented by: H. Höfler, C. Kahle and V. Winkler, lawyers)

Applicant:

Defendant: European Commission (represented by: T. Maxian Rusche and R. Sauer, lawyers)

Defendant:

Re:

Re:

Application for suspension of the legal effects of the decision by which the Commission opened a formal investigation procedure in respect of State aid concerning the German law on renewable energy.

Operative part of the order

Operative part of the order

| 1. | The application for interim measures is dismissed. |
| --- | --- |

1.

The application for interim measures is dismissed.

| 2. | The judgment in Case T-173/14 R WeserWind v Commission is set aside |
| --- | --- |

2.

The judgment in Case T-173/14 R WeserWind v Commission is set aside

| 3. | Costs are reserved. |
| --- | --- |

3.

Costs are reserved.

---
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.9 Limitations of exemptions from section 510(k) of the Federal Food, Drug, and Cosmetic Act (the act). The exemption from the requirement of premarket notification (section 510(k) of the act) for a generic type of class I or II device is only to the extent that the device has existing or reasonably foreseeable characteristics of commercially distributed devices within that generic type or, in the case of in vitro diagnostic devices, only to the extent that misdiagnosis as a result of using the device would not be associated with high morbidity or mortality. Accordingly, manufacturers of any commercially distributed class I or II device for which FDA has granted an exemption from the requirement of premarket notification must still submit a premarket notification to FDA before introducing or delivering for introduction into interstate commerce for commercial distribution the device when: ( a ) The device is intended for a use different from the intended use of a legally marketed device in that generic type of device; e.g., the device is intended for a different medical purpose, or the device is intended for lay use where the former intended use was by health care professionals only;
( b ) The modified device operates using a different fundamental scientific technology than a legally marketed device in that generic type of device; e.g., a surgical instrument cuts tissue with a laser beam rather than with a sharpened metal blade, or an in vitro diagnostic device detects or identifies infectious agents by using deoxyribonucleic acid (DNA) probe or nucleic acid hybridization technology rather than culture or immunoassay technology; or
( c ) The device is an in vitro device that is intended: ( 1 ) For use in the diagnosis, monitoring, or screening of neoplastic diseases with the exception of immunohistochemical devices;
( 2 ) For use in screening or diagnosis of familial or acquired genetic disorders, including inborn errors of metabolism;
( 3 ) For measuring an analyte that serves as a surrogate marker for screening, diagnosis, or monitoring life-threatening diseases such as acquired immune deficiency syndrome (AIDS), chronic or active hepatitis, tuberculosis, or myocardial infarction or to monitor therapy;
( 4 ) For assessing the risk of cardiovascular diseases;
( 5 ) For use in diabetes management;
( 6 ) For identifying or inferring the identity of a microorganism directly from clinical material;
( 7 ) For detection of antibodies to microorganisms other than immunoglobulin G (IgG) or IgG assays when the results are not qualitative, or are used to determine immunity, or the assay is intended for use in matrices other than serum or plasma;
( 8 ) For noninvasive testing as defined in § 812.3(k) of this chapter; and
( 9 ) For near patient testing (point of care).
[65 FR 2313, Jan. 14, 2000]
§ 884.2800 Computerized Labor Monitoring System. ( a ) *Identification.* A computerized labor monitoring system is a system intended to continuously measure cervical dilation and fetal head descent and provide a display that indicates the progress of labor. The computerized labor monitoring system includes a monitor and ultrasound transducers. Ultrasound transducers are placed on the maternal abdomen and cervix and on the fetal scalp to provide the matrix of measurements used to produce the display.
( b ) *Classification.* Class II (special controls). The special controls are the FDA guidance document entitled: “Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Computerized Labor Monitoring Systems.” See § 884.1(e) for availability of this guidance document.
[72 FR 20227, Apr. 24, 2007]
Editorial Note on Part 872
Editorial Note: Nomenclature changes to part 872 appear at 73 FR 35341, June 23, 2008.

§ 872.5410 Orthodontic appliance and accessories. ( a ) *Identification.* An orthodontic appliance and accessories is a device intended for use in orthodontic treatment. The device is affixed to a tooth so that pressure can be exerted on the teeth. This device includes the preformed orthodontic band, orthodontic band material, orthodontic elastic band, orthodontic metal bracket, orthodontic wire clamp, preformed orthodontic space maintainer, orthodontic expansion screw retainer, orthodontic spring, orthodontic tube, and orthodontic wire.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 872.9.
[52 FR 30097, Aug. 12, 1987, as amended at 59 FR 63009, Dec. 7, 1994; 66 FR 38799, July 25, 2001]
Michigan Supreme Court

Lansing, Michigan

Stephen J. Markman, Chief Justice

Brian K. Zahra

Bridget M. McCormack

David F. Viviano 

Richard H. Bernstein

Kurtis T. Wilder

Elizabeth T. Clement, Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 June 11, 2018

Order 

Clerk

June 11, 2018

157467(12)

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff-Appellee,

SC: 157467

v COA: 341840

Wayne CC: 17-003202-FC

DARIUS JOVAN JONES, Defendant-Appellant.

_________________________________________/

On order of the Chief Justice, the motion of defendant-appellant to file a supplement 

to the application for leave to appeal is GRANTED. The supplement submitted on June 4, 

2018, is accepted for filing.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### National Science Foundation

      ( print page 10328)    
In accordance with Federal Advisory Committee Act (Pub. L. 92-463, as amended), the  National Science Foundation announces the following meeting:

*Name:*                     Advisory Committee for Mathematical and Physical Sciences (#66)                

*Date/Time:*                     April 1, 2010, 9 a.m.-6 p.m.; April 2, 2010, 9 a.m-3 p.m.                

*Place:*                     National Science Foundation, RM 375, 4201 Wilson Boulevard, Arlington, VA 22230.                

*Type of Meeting:*                     Open.                

*Contact Person:*                     Dr. Morris L. Aizenman, Senior Science Associate, Directorate for Mathematical and Physical Sciences, Room 1005, National Science Foundation, 4201 Wilson Boulevard, Arlington, VA 22230. (703) 292-8807.                

*Purpose of Meeting:*                     To provide advice and recommendations concerning NSF science and education activities within the Directorate for Mathematical and Physical Sciences.                

*Agenda:*

Update on current status of Directorate;

Report of NSF Advisory Working Groups;

Meeting of MPSAC with Divisions within MPS Directorate;

Discussion of MPS Long-term Planning Activities.

*Summary Minutes:*                     May be obtained from the contact person listed above.                

Dated: March 2, 2010.

Susanne E. Bolton,

Committee Management Officer.

[FR Doc. 2010-4678 Filed 3-4-10; 8:45 am]

BILLING CODE 7555-01-P
### T E X A S C O U R T O F A P P E A L S , T H I R D D I S T R I C T , A T A U S T I N
NO. 03-15-00822- CR

Bobb ie G utierr ez, A ppellan t

v. The State of Texas, App ellee

F ROM TH E DISTRI CT COURT O F H AY S CO UNTY, 274 TH JUDICI AL DISTRICT NO. CR-13 -09 01, TH E H ONO RAB LE GARY L. STEEL, JUDGE P RESIDING

M E M O R A N D U M O P I N I O N Appellant Bobbie Gutierre z has filed a motion to dismiss her appea l, which is signe d by appellant and her counsel in compliance with the Texas Rules of Appellate Procedur e. See Tex. R. App. P. 42.2(a). We g rant the motion and dismiss the appea l. See Tex. R. App. P . 42.2(a)
.

__________________________________________ Melissa Goodwin, Jus tice Be fore J ustices Pury ear , Goodwin, and F ield Dismissed on Appellant’s Motion Filed: Apr il 19, 2016 Do Not Publish